Project Grant HT94252510259
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$778K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This $729,778 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The 3-year award to the University of Wisconsin System, which commenced on June 1, 2025, will fund advanced research into transforming healthcare for military service members and the broader public through innovative scientific investigations...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
The University of Wisconsin System has been awarded a $516,366 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will fund research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. This research initiative aims to transform healthcare for military service members and the broader...
This federal Project Grant award, valued at $1,555,000.00 and provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will fund research at the University of Wisconsin - Madison to develop population modeling approaches for optimizing equitable ovarian cancer outcomes. The research efforts aim to transform healthcare for military service members and the general public by advancing innovative and impactful biomedical...
This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
This $1,146,270 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System to target a lipid kinase regulator of nuclear Akt in breast cancer. The project aims to transform health care for Service Members and the American public through innovative and impactful research, with a focus on medical solutions for the battlefield. The grant will fund research activities at the University of...
This federal Project Grant award of $459,747.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Wisconsin-Madison to define the effect of copy number amplification on the regulation of oncogenes in high-grade serous ovarian carcinoma. The research will examine the contributions of superenhancers at the 8q22 region, with the goal of advancing scientific understanding and potential treatment...
The University of Wisconsin-Madison received a $1,166,250 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund a research project titled "LIQUID BIOMARKERS OF RESPONSE AND RESISTANCE TO 177LU-PSMA" from August 1, 2022 through July 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goal of...
The Department of the Army Medical Command awarded a $537,120 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program. The grant will support targeted combination therapy research in a novel in vivo model of fibrolamellar carcinoma from August 1, 2022 to July 31, 2024. The Military Medical Research and Development program aims to advance biomedical research that transforms military and public health care. This award will fund the...